Medifocus Inc. Announces That It Has Received Approval for Its Amended Phase III Clinical Trial for Treatment of Breast Cancer from Health Canada
The Approval Allows the Company to Pool Patient Data from Canada and the USA for Use towards Obtaining Commercial Approval from Both Countries Press Release Source: Medifocus, Inc. On Thursday May 13, 2010, 10:00 am EDT
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.